Nicorette Whitemint (Nicotine)

Nicotine, the active ingredient in Nicorette Whitemint, is a nicotinic agonist presented as a / for oromucosal use. It is employed to help adult smokers reduce dependence on tobacco and manage nicotine withdrawal symptoms during cessation attempts. The product is available in the European market and conforms to relevant regulatory standards.

GNH USA supplies Nicorette Whitemint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals and clinics worldwide, providing reliable sourcing and quality assurance for nicotine replacement therapy products.

Nicotine, delivered as Nicorette Whitemint, is used in nicotine replacement therapy to support smoking cessation.

- Smoking cessation: assists adult smokers in reducing nicotine cravings and withdrawal symptoms during quit attempts.

Nicorette Whitemint may cause a range of adverse reactions. Most are mild and resolve after continued use.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Nausea: transient feeling of queasiness. - Dizziness: light‑headed sensation, especially on initial use. - Headache: mild to moderate pain.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or swelling. - Chest pain: may indicate cardiovascular stress. - Irregular heartbeat: palpitations or arrhythmia. - Severe skin rash: widespread erythema or blistering. - Swelling of face/lips: angioedema requiring immediate medical attention. - Difficulty breathing: respiratory distress or wheezing.

Before using Nicorette Whitemint, consider the following safety measures.

- Cardiovascular assessment: evaluate recent heart events before initiating therapy. - Pregnancy caution: safety data are limited; discuss risks with a healthcare professional. - Pediatric restriction: not intended for use by children. - Concomitant nicotine products: avoid using other nicotine sources simultaneously. - Storage: Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Nicotine can interact with several medicines, altering their effects or increasing adverse reactions.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may precipitate hypertensive crisis. - Beta‑blockers: nicotine may diminish their antihypertensive efficacy. - Insulin: nicotine can affect glucose control, requiring dose adjustment.

Moderate Interactions (Monitor Closely): - Caffeine: combined use may increase stimulation and jitteriness. - Alcohol: may enhance nicotine’s cardiovascular effects. - Antipsychotics: nicotine may alter plasma concentrations of certain agents.